A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Haemonetics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,655 shares of HAE stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,655
Previous 46,755 55.82%
Holding current value
$1.75 Million
Previous $3.87 Million 57.08%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.45 - $91.58 $1.89 Million - $2.39 Million
-26,100 Reduced 55.82%
20,655 $1.66 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $1.28 Million - $1.54 Million
-15,800 Reduced 25.26%
46,755 $3.87 Million
Q1 2024

May 15, 2024

SELL
$71.24 - $85.35 $4.83 Million - $5.79 Million
-67,800 Reduced 52.01%
62,555 $5.34 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $7.29 Million - $8.37 Million
-90,400 Reduced 40.95%
130,355 $11.1 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $2.46 Million - $2.79 Million
-29,800 Reduced 11.89%
220,755 $19.8 Million
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $2.54 Million - $2.81 Million
-31,400 Reduced 11.14%
250,555 $21.3 Million
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $1.78 Million - $2.22 Million
-24,500 Reduced 7.99%
281,955 $23.3 Million
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $2.95 Million - $3.45 Million
-40,000 Reduced 11.55%
306,455 $24.1 Million
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $4.11 Million - $5.11 Million
-64,900 Reduced 15.78%
346,455 $25.6 Million
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $206,934 - $277,536
-4,200 Reduced 1.01%
411,355 $26.8 Million
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $5.04 Million - $7.28 Million
115,100 Added 38.31%
415,555 $26.3 Million
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $193,245 - $290,901
3,900 Added 1.32%
300,455 $15.9 Million
Q3 2021

Nov 15, 2021

BUY
$57.6 - $70.59 $11.1 Million - $13.6 Million
192,600 Added 185.27%
296,555 $20.9 Million
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $3.34 Million - $7.65 Million
-64,500 Reduced 38.29%
103,955 $6.93 Million
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $11.2 Million - $14.1 Million
-101,300 Reduced 37.55%
168,455 $18.7 Million
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $21 Million - $28.4 Million
-236,700 Reduced 46.74%
269,755 $32 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $16.8 Million - $20.8 Million
222,100 Added 78.11%
506,455 $44.2 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $8.14 Million - $11.4 Million
95,800 Added 50.81%
284,355 $25.5 Million
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $713,664 - $1.17 Million
9,600 Added 5.36%
188,555 $18.8 Million
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $4.51 Million - $5.1 Million
39,400 Added 28.23%
178,955 $20.6 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $790,244 - $934,317
-6,745 Reduced 4.61%
139,555 $17.6 Million
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $2.31 Million - $3.4 Million
-28,255 Reduced 16.19%
146,300 $17.6 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $1.74 Million - $2.13 Million
20,855 Added 13.57%
174,555 $15.3 Million
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $743,865 - $956,949
-8,205 Reduced 5.07%
153,700 $15.4 Million
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $3.08 Million - $3.92 Million
-34,255 Reduced 17.46%
161,905 $18.6 Million
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $3.01 Million - $4.03 Million
42,060 Added 27.29%
196,160 $17.6 Million
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $9.67 Million - $11.8 Million
-159,205 Reduced 50.81%
154,100 $11.3 Million
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $9.86 Million - $12.9 Million
219,300 Added 233.29%
313,305 $18.2 Million
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $3.8 Million - $4.22 Million
94,005
94,005 $4.22 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.